You are currently viewing a new version of our website. To view the old version click .

Uro, Volume 3, Issue 3

September 2023 - 5 articles

Cover Story: Urinary incontinence is a prevalent condition, especially in elderly men, with stress urinary incontinence (SUI) being a common cause following radical prostatectomy. The artificial urinary sphincter (AUS), particularly the AMS 800™ device, has been the gold-standard treatment for moderate–severe male SUI for decades. Despite some technical advancements and alternative devices like ZSI-375, Victo, and BR-SL-AS 904 being introduced, there is limited literature comparing their effectiveness to the AMS 800™. We reviewed the current literature on urinary sphincter implants in male stress incontinence, including AMS 800™, ZSI-375, Victo, and BR-SL-AS 904. AMS 800™ remains the gold-standard treatment for SUI after radical prostatectomy. Alternative devices show promising results, but longer studies and more data are needed to establish their effectiveness and safety compared with the AMS 800™. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Review
  • Open Access
1 Citations
3,713 Views
10 Pages

Urinary Artificial Sphincter in Male Stress Urinary Incontinence: Where Are We Today? A Narrative Review

  • Anna Ricapito,
  • Matteo Rubino,
  • Pasquale Annese,
  • Vito Mancini,
  • Ugo Falagario,
  • Luigi Cormio,
  • Giuseppe Carrieri,
  • Gian Maria Busetto and
  • Carlo Bettocchi

6 September 2023

Introduction: Urinary incontinence is a prevalent condition, especially in elderly men, with stress urinary incontinence (SUI) being a common cause after radical prostatectomy. The artificial urinary sphincter (AUS), particularly the AMS 800™ device,...

  • Review
  • Open Access
4 Citations
7,382 Views
21 Pages

Effectiveness of Silymarin, Sulforaphane, Lycopene, Green Tea, Tryptophan, Glutathione, and Escin on Human Health: A Narrative Review

  • Francesco Sebastiani,
  • Carlo D’Alterio,
  • Cristina Vocca,
  • Luca Gallelli,
  • Fabrizio Palumbo,
  • Tommaso Cai and
  • Alessandro Palmieri

9 August 2023

Background: Recently, the role of nutraceutical compounds in the prevention of human diseases has been rapidly increasing. Here, we aim to evaluate the beneficial effect of dietary supplementation with seven active principles, i.e., lycopene, sulfora...

  • Article
  • Open Access
1 Citations
8,872 Views
9 Pages

Efficacy and Safety of a Natural Supplement Containing Serenoa Repens, Solanum Lycopersicum, Lycopene, and Bromelain in Reducing Symptoms of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective Cohort Study in 250 Patients

  • Luca Lambertini,
  • Alessandro Sandulli,
  • Vincenzo Salamone,
  • Mara Bacchiani,
  • Sofia Giudici,
  • Eleana Massaro,
  • Anna Cadenar,
  • Riccardo Mariottini,
  • Simone Coco and
  • Laia Bardina
  • + 9 authors

20 July 2023

Background: Chronic Prostatitis/Chronic Pelvic Pain syndrome NIH-class III is a widespread condition affecting men universally, with existing treatments showing limited success. This study evaluated the efficacy and safety of a natural supplement, co...

  • Case Report
  • Open Access
3,262 Views
10 Pages

Adult-Type Granulosa Cell Tumor of the Testis: A Report of a Case and a Discussion of the Literature

  • Georgios Zervopoulos,
  • Nikolaos Mitsimponas,
  • Filippos Venetsanos and
  • Athanasios Papathanasis

3 July 2023

Testicular granulosa cell tumors (TGCTs) are rare tumors of sex cord-stromal origin. TGCTs are classified into two main categories, the adult type and the juvenile type. The adult type is extremely rare, with only 93 known cases reported in the liter...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Uro - ISSN 2673-4397